AtriCure (ATRC) Short-term Investments (2010 - 2024)

AtriCure (ATRC) has 15 years of Short-term Investments data on file, last reported at $8.0 million in Q2 2024.

• Short-term Investments for Q2 2024 came in at $8.0 million, down 86.64% year-over-year; the trailing twelve-month figure through Jun 2024 was $8.0 million (down 86.64% YoY), and the FY2023 annual result was $53.0 million, down 15.93% from the prior year.
• Short-term Investments eased to $8.0 million in Q2 2024 per ATRC's latest filing, from $41.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $202.3 million in Q4 2020 and troughed at $8.0 million in Q2 2024.
• A 5-year average of $85.5 million and a median of $68.9 million in 2022 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2020 and 2024: Short-term Investments soared 328.91% in 2020, then sank 86.64% in 2024.
• A 5-year view of Short-term Investments shows it stood at $202.3 million in 2020, then plunged by 62.71% to $75.4 million in 2021, then fell by 16.47% to $63.0 million in 2022, then dropped by 15.93% to $53.0 million in 2023, then sank by 84.93% to $8.0 million in 2024.
• Business Quant data shows ATRC's Short-term Investments at $8.0 million in Q2 2024, $41.0 million in Q1 2024, and $53.0 million in Q4 2023.